Retail and Healthcare Experts
817.200.7620
Home » Tenants » Rite Aid

Rite Aid



www.riteaid.com
Average Sale and Lease Details
Price Range 12mo avg: $793K – $7.3M
$/sf 12mo avg: $263.80
CAP Rate 12mo avg: 8.02%
NOI average: $246,946
Lease Terms: 20yrs NN
Building Size avg: 12,400 SF
Lot Size avg: 1.80+/- acres

Rite Aid is the third largest retail drugstore chain in the United States based on both revenues
and number of stores. As of March 1, 2014, Rite Aid operated 4,587 stores in 31 states across the country and in the District of Columbia.
Rite Aid stores sell prescription drugs and a wide assortment of other merchandise, which they call
‘‘front-end’’ products. In fiscal 2014, prescription drug sales accounted for 67.9% of the company total sales. Rite Aid believes that pharmacy operations will continue to represent a significant part of the company business due to favorable industry trends, including an aging population, increased life expectancy, anticipated growth in the federally funded Medicare Part D prescription program as ‘‘baby boomers’’ start to enroll, expanded coverage for uninsured Americans as the result of the Patient Protection and Affordable Care Act and the discovery of new and better drug therapies. Rite Aid carry a full assortment of front-end products, which accounted for the remaining 32.1% of their total sales in fiscal 2014. Front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. Rite Aid also offers various photo processing services in virtually all their stores.
Rite Aid differentiate their stores from other national chain drugstores, in part, through their wellness+ loyalty program, their Wellness format stores, innovative merchandising, private brands and Rite Aid’s expanded strategic partnership with GNC, a leading retailer of vitamin and mineral supplements. Rite Aid offers a wide variety of products through their portfolio of private brands, which continue to be well received by their customers. Private brand items contributed approximately 18.2% of their front-end sales in fiscal 2014.

S&P Credit Rating: B
Moody’s Credit Rating: B2
Annual Revenue 2014: $25.5B
Annual Revenue 2013: $25.4B
Revenue Growth: ↑ 0.5% from 2013
Net Income $249.4M
Units (Mar. 2014) 4,587
Average Units Volume: $5.8M

Yahoo! Finance: RAD News Latest Financial News for RAD

  • Rite Aid's (RAD) Q4 Loss Narrower Than Expected, Sales Beat
    on April 16, 2021 at 2:23 pm

    Rite Aid's (RAD) Q4 results gain from RxEvolution strategy, strength in Elixir brand and robust online growth. However, COVID-related costs woes and lesser cases of cough, cold and flu are concerns. […]

  • Rite Aid (RAD) Q4 2021 Earnings Call Transcript
    on April 16, 2021 at 4:30 am

    RAD earnings call for the period ending March 31, 2021. […]

  • Rite Aid reports narrower losses, sales beat
    on April 15, 2021 at 11:30 am

    Rite Aid Corp. shares rose 1.3% in Thursday premarket trading after the pharmacy retailer reported a fourth-quarter sales beat. Net losses totaled $18.5 million, or 34 cents per share, after a loss of $324.7 million, or $6.08 per share, last year. Adjusted losses of 78 cents per share were ahead of the FactSet consensus for a loss of 90 cents per share. Revenue of $5.92 billion was up from $5.73 billion last year and also ahead of the FactSet consensus for $5.85 billion. The quarter was impacted by "a historically soft cough, cold and flu season, the deferral of elective procedures and related acute prescription volume and the impact of COVID-19 on selling, general and administrative expenses," Chief Executive Heyward Donigan said in a statement. For March and April to date, Rite Aid has administered two million COVID-19 vaccine shots, and Donigan said prescription trends heading back "to positive levels." For the first quarter, Rite Aid is guiding for net income between $10 million and a net loss of $10 million and retail pharmacy revenue between $6.1 billion and $6.3 billion. The company expects COVID-19 to continue to have an impact. The FactSet consensus is for pharmacy sales of $6.084 billion. Rite Aid stock is up 20.3% for the year to date while the S&P 500 index [s spx] has gained 9.8% for the period. […]

  • Rite Aid Corporation Reports Fiscal 2021 Fourth Quarter and Full Year Results
    on April 15, 2021 at 11:00 am

    Rite Aid Corporation (NYSE: RAD) today reported operating results for its fourth quarter and fiscal year ended February 27, 2021. […]

  • Rite Aid Corp. to Host Earnings Call
    on April 15, 2021 at 10:15 am

    NEW YORK, NY / ACCESSWIRE / April 15, 2021 / Rite Aid Corp. (NYSE:RAD) will be discussing their earnings results in their 2021 Fourth Quarter Earnings call to be held on April 15, 2021 at 8:30 AM Eastern Time. […]

NYSE: RAD

Rite Aid

Annual Reports

annual reports